Legionella Testing Market

Legionella Testing Market Outlook from 2024 to 2034

The legionella testing market is expected to be worth USD 355.1 million in 2024. Diseases caused by Legionella require intensive care and hospitalization as it is considered one of the public health concerns.

The need for legionella testing is projected to rise at a promising CAGR of 9.9% through 2034. The industry is projected to surpass USD 910 million by 2034. The rise in prevalence of Legionella-related disorders and the surge in awareness about their preventive management is anticipated to drive growth of the market.

Attributes	Details
Legionella Testing Market Value for 2024	USD 355.1 million
Legionella Testing Market Value for 2034	USD 910 million
Legionella Testing Market Forecast CAGR for 2024 to 2034	9.9%

Key Highlights of the Legionella Testing Industry

• The legionella testing industry has validated technological advancements, certainly leading to the development of more authentic and efficient testing methods.
• Boom in the availability of rapid testing kits for legionella, thus, offering on-site testing capabilities with quick results.
• Symbolic increase in demand for Legionella testing services can be seen leading to growth in awareness of Legionnaires' disease and its probable impact on public health.
• The Legionella testing market has accomplished significant growth globally, driven by rise in awareness of regulatory requirements and technological advancements.

Historical Performance and Future Growth of the Legionella Testing Market

Historical CAGR	12.4%
Forecast CAGR	9.9%

The historical CAGR of the Legionella testing market was 12.4%, indicating an impressive rate over the past few years. The forecast CAGR is expected to be 9.9%, indicating a steady decrease in the growth rate through 2034.

• The business tests required for Legionella are focusing more on education and training as the awareness of the disease spreads.
• Environmental evaluations, risk management advice, and remediation services are some of the services provided by the Legionella testing sector in addition to standard water testing.

The forecast CAGR of 9.9% indicates a decrease in the growth rate of the market in comparison to the historical CAGR in the future. The fall in CAGR can be attributed to several factors, including

• Modifications in customer priorities or preferences about Legionella risk control techniques may impact the demand for testing services. For example, the demand certainly increases more slowly when certain clients prioritize investments in other areas of facility management or embrace other risk mitigation strategies.
• Unpredicted occurrences, like natural catastrophes, international health emergencies, or geopolitical unrest, might alter market dynamics and impact the market growth trajectory.

Key Threats Hampering the Legionella Testing Market

• Certain facilities may disregard regulatory standards because they lack the necessary resources, oversight, or knowledge of the rules, resulting in gaps required for testing and possible epidemics.
• Due to the rise in financial limitations, some companies might prioritize other expenses over Legionella testing, leaving them vulnerable to outbreaks and legal repercussions.
• The complexity of the testing process might be a barrier, resulting in poor or ineffective testing techniques for certain facilities, especially those with little technical experience or resources

Country-wise Insights

The table analyses the top five countries ranked by revenue, with South Korea holding the top position.

Due to government initiatives and technological advancements, South Korea is considered a prominent market. Stringent regulations and proactive measures to improve public health have spurred widespread adoption of Legionella testing in various facilities.

South Korea is a hub for technological innovation, which has led to the development of advanced testing methods and solutions. It is positioning it itself to be a leader in Legionella risk management.

The Forecast CAGRs from 2024 to 2034

Countries	CAGR
United States	10.1%
United Kingdom	11.1%
China	10.5%
Japan	11.4%
South Korea	12%

Stringent Regulatory Requirements Impresses the United States Market

The industry in the United States is heavily utilized due to stringent regulatory requirements imposed by federal and state agencies. Regulations mandate that Legionella testing be done in various facilities, such as healthcare facilities, hotels, and industrial sites, to ensure public health and safety.

High Incidence of Legionnaires Disease Drives the United Kingdom Market

Due to the relatively high incidence of Legionnaires disease, the industry is heavily utilized in the United Kingdom. The surge in awareness and proactive testing measures are taken to prevent future outbreaks in the country.

Rapid Urbanization and Industrialization Grabs Attention towards the China Market

Large-scale infrastructure projects, industrial facilities, and high-rise structures are expanding due to the growth in industrialization and urbanization of the country.

The primary purpose is to reduce the possibility of Legionella contamination in such environments, where dense populations and intricate water systems encourage bacterial growth.

Aging Infrastructure and Public Health Concerns Booms Market Growth in Japan

The aging infrastructure and burgeoning geriatric population in Japan have raised worries over public health and safety.

To ensure public health and safety, the industry widely mitigates the danger of Legionella contamination in public water systems, healthcare facilities, and older buildings.

Government Initiatives and Technological Advancements Boost South Korea Market

Government initiatives to improve public health and safety have prompted the adoption of Legionella testing measures.

The focus on technological advancements and innovation has led to the development of advanced testing methods and solutions, thus driving growth in the industry.

Category-wise Insights

The below section shows the leading segment. Based on type, the urine antigen testing (UAT) segment is registered to expand at 9.7% CAGR by 2034. Based on end-user, the clinical laboratories segment is registered to rise at 9.5% CAGR by 2034.

UAT provides quick, non-invasive results without requiring invasive procedures or specialist equipment for rapid detecteion of Legionella antigens in urine samples.

The rise in demand for diagnostic services is driven by factors such as population growth, aging demographics, and the rising prevalence of chronic diseases.

Category	CAGR from 2024 to 2034
Urine Antigen Testing (UAT)	9.7%
Clinical Laboratories	9.5%

Urine Antigen Testing (UAT) Segment to Hold a Significant Share in the Market

The urine antigen testing (UAT) segment is projected to expand at a CAGR of 9.7% by 2034, driven by its effectiveness and convenience in diagnosing ligionnaires disease.

UAT is becoming more popular as it offers rapid results and high sensitivity in detecting Legionella antigens in urine samples, where adoption is increasing, particularly in clinical settings and timely diagnosis is crucial for patient management.

Clinical Laboratories Segment to Hold a Dominant Share in the Market

Based on end-use, the clinical laboratories market expanded at 9.5% CAGR. There is a boost in demand for clinical laboratories diagnostic services, inclusive of Legionella antigen urine testing.

Clinical laboratories play a critical role in healthcare delivery by offering precise and dependable diagnostic tests, improving patient outcomes, and managing diseases.

Growth in the market is expected as urine antigen testing services are in constant demand from clinical laboratories due to the surge in frequency of Ligionnaires' disease.

Competitive Landscape

Innovative entrepreneurs have used technological breakthroughs to challenge existing players of traditional testing methods in the highly competitive market sector inside the startup ecosystem.

The firms are introducing new testing solutions, like IoT-enabled monitoring devices, AI-powered analytics platforms, and quick testing kits. By providing affordable, user-friendly, and scalable solutions, they have challenged established players and gained traction with industrial sites, healthcare facilities, and other end customers.

Startups prioritizing agility, innovation, and customer-centricity are changing the market and raising competition, certainly leading to better risk management techniques and public health results.

Key developments in the Legionella Testing industry

• In May 2022, ChemREADY, launched a novel line of Legionella testing services and products for combating water-borne infections in building water systems. The move underscored the commitment to enhance public health and safety through innovative solutions.
• In March 2022, IDEXX announced a significant milestone with its Legiolert test, designed to rapidly detect Legionella pneumophila. ASTM International officially recognized the test as 'ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert'.

Key Coverage in the Legionella Testing Industry Report

• Adjacent Study on Legionella Testing Market
• Asia Pacific Legionella Testing Market
• Legionella Testing Market Size, Current Insights, and Demographic Trends
• Demand for Legionella Testing Market
• Key Strategies in Global Legionella Testing Market

Report Scope

Attributes	Details
Estimated Market Size in 2024	USD 355.1 million
Projected Market Valuation in 2034	USD 910 million
Value-based CAGR 2024 to 2034	9.9%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in USD million
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa
Key Market Segments Covered	Type, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel
Key Companies Profiled	Quidel Corporation; Abbott (Alere); Merck KGaA; Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; Pro-lab Diagnostics Inc.; bioMerieux; IDEXX Corporation; Eurofins Scientific; Beckman Coulter Inc.

Key Segments

By Type:

• Culture Media
• Urine Antigen Testing (UAT)
• Polymerase Chain Reaction (PCR)
• Serology
• Direct Fluorescent Antibody (DFA) Test

By End User:

• Hospitals & Clinics
• Clinical Laboratories
• Others

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia and Pacific
• East Asia
• Middle East and Africa

Frequently Asked Questions

What is the expected worth of the Legionella testing market in 2024?

As of 2024, the market for Legionella testing is expected to be valued at USD 355.1 million.

What is the market potential for Legionella testing?

The Legionella testing market is projected to expand at a CAGR of 9.9 % between 2024 and 2034.

Which type of segment dominates the Legionella testing market?

The urine antigen testing (UAT) segment is projected to dominate the industry.

What is the anticipated market value for Legionella testing in 2034?

By 2034, the market value of Legionella testing is expected to reach USD 910 million.

Which country is likely to dominate the Legionella testing market?

South Korea is likely the top-performing market, with a CAGR of 12%.